Northern Trust Corp Immuno Precise Antibodies Ltd. Call Options Transaction History
Northern Trust Corp
- $709 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IPA
# of Institutions
27Shares Held
4MCall Options Held
77.9KPut Options Held
0-
Ingalls & Snyder LLC New York, NY2.78MShares$5.61 Million0.1% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA699KShares$1.41 Million0.0% of portfolio
-
Xtx Topco LTD London, X091.4KShares$184,5910.0% of portfolio
-
Two Sigma Investments, LP New York, NY90.9KShares$183,5270.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$83,2240.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $50.2M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...